Entry-level genetic report companies by Roberto Grobman 2023: Our Story: FullDNA has identified the need for creating a tool for healthcare professionals to access useful valuable genetic data from the big data pool of 21 million publications and growing daily roughly 2.5 million new publications every year. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Read more details on DNA report solutions.
How will hospitals and doctors be able to use our DNA data? Imagine if our doctor and the hospitals treating us had additional insights into our individual response to medication. The opportunity to enhance our treatment plan could be really beneficial. In practice, right now, that could happen with a doctor or patient sharing their pharmacogenomics report. In order to be effective at scale we would need to see pharmacogenomics results and reports stored in a patient’s electronic health record.
High quality DNA report solutions from Prof. Roberto Grobman: What are the benefits and risks of direct-to-consumer genetic testing? Direct-to-consumer genetic testing has both benefits and limitations, as they are somewhat different than those of genetic testing ordered by a healthcare provider. Benefits: Direct-to-consumer genetic testing promotes awareness of genetic diseases. It provides personalized information about your health, disease risk, and other traits. It may help you be more proactive about your health. It does not require approval from a healthcare provider or health insurance company.
When it comes to health and disease — and, of course, many other aspects of life — one thing is certain: genes matter. A single gene mutation can cause some conditions, such as sickle cell anemia and cystic fibrosis. More often, multiple genes are involved in disease development, and they act in concert with nongenetic factors, such as diet or exercise, to affect disease risk. Several companies offer you the opportunity to look at your genes. But how might that help you from a health standpoint? And how do such tests differ from the genetic testing a doctor may recommend?
Within DNA testing, it is also important to know: is a given gene one that is modifiable? Do we know that with easily actioned lifestyle or environmental changes, someone can make a difference to a given factor? As such it means a lot to us to have the right kind of science and governance behind it. For example, we have a robust scientific advisory board that conducts the evidence inclusion protocol. This includes consensus of multiple peer-reviewed research studies so we know that an outcome is reliable. It’s really important to understand that.
Our mid-level genetic report encompasses broader sets of relevant genomic variants for Health and Wellness Panels. Essential Reports provide patient-specific information, determined by his genetics, which allows the user to know what their genetic tendencies are, with additional information than the First Panel, thus maintaining their Health, Vitality, Beauty and Longevity. FullDNA CEO Roberto Grobman says that the University of Washington provided some samples of the Covid-19 receptor for the development of the research. See more information at Prof. Roberto Grobman.